wechat public accounts

Address: Building F2, No. 88, Kechuang 6th Street, Beijing Economic Development Zone

Tel: +86  010-56315466

Fax: +86  010-56315314

E-mail: hr@jacobiopharma.com

             bd@jacobiopharma.com

 

 

百度地图API自定义地图

Copyright: JACOBIO PHARMACEUTICALS GROUP CO., LTD.   Beijing ICP preparation 17065868-1   

 

Steve Zhou/ Senior Vice President

 

  • Dr. Zhou has extensive experience in the research and development in the field of oncology. Dr. Zhou used to serve as a laboratory head and research investigator at Oncology Department at Novartis Institutes for BioMedical Research, Inc.
  • Dr. Zhou obtained his doctoral degree in molecular biology from the University of Melbourne. From December 2007 to November 2008, Dr. Zhou served as a post-doctoral scholar at the School of Medicine of University of California, San Diego.

Yinxiang Wang/ Chief Executive Officer, Chairman of our Board

 

  • Dr. Wang co-founded Zhejiang Betta Pharmaceuticals Co., Ltd. (浙江貝達藥業有限公司), where he served as a director and the general manager (總經理). He also served as a director and the president (總裁) Betta Pharmaceuticals Co., Ltd. (貝達藥業股份有限公司) (Shenzhen Stock Exchange stock code: 300558) (“Betta Pharma”), the successor of Zhejiang Betta Pharmaceuticals Co., Ltd. In addition, Dr. Wang used to serve as a post-doctoral fellow at Koleske Lab of Yale University which focuses on research in the fields of molecular biology and biochemistry.
  • Dr. Wang obtained his doctoral degree in biochemistry and molecular biology from University of Arkansas for Medical Sciences.

Shaojing Hu/ President of Research and Development

 

  • Dr. Hu has extensive experience in the pharmaceutical industry and academic research. Prior to joining our Group, from March 2009 to January 2017, Dr. Hu served as the chief chemist at Betta Pharma. Over the years, Dr. Hu has published a number of first-authored and co-authored academic papers in the chemistry field.
  • Dr. Hu obtained his doctoral degree in chemistry from Simon Fraser University.

 

 
 

Xiaojie Wang/President of Administration

 

  • Ms. Wang has more than 17 years of experience in the pharmaceutical industry. Prior to joining our Group, Ms. Wang worked at Betta Pharma, where she served as a vice president prior to her resignation.
  • Ms. Wang obtained her bachelor’s degree in sugar engineering from Dalian Institute of Light Industries (大連輕工業學院) (currently known as Dalian Polytechnic University (大連工業大學). Ms. Wang completed a postgraduate program in business administration offered by Peking University (北京大學) and a program for executive masters of business administration with a focus on the nationwide medical industry offered by Peking University.
 
 
 

Yunyan Hu/ Senior Vice President

 

 

  • Ms. Hu has more than 16 years of experience in the pharmaceutical industry. Prior to joining our Group, between 2004 to August 2013, Ms. Hu served as the director of the drug analysis office, director of the quality control department and deputy director of research and development at the Beijing research and development center of new drugs of Zhejiang Betta Pharmaceuticals Co., Ltd. Ms. Hu also served as the deputy director of research and development center at Betta Pharma.
  • Ms. Hu graduated from an undergraduate program in analytical chemistry offered by Lanzhou University and obtained her master’s degree in analytical chemistry from the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (中國科學院蘭州化學物理研究所).
 
 
 
 
 
 
 

Wayne Long/Vice President Chemistry

 

  • Former Assistant Director, R&D center of Betta
  • Beijing University of Technology, Ph.D.
  • Health Science Center at Beijing University, Postdoc
 
 

Qiao Li/Vice President Biostatistics and Data Science

 

  • Head of Biostatistics and Programming, Astellas (China)
  • Head of Biostatisitcs, Novo Nordisk (China)
  • Imperial College London, Post-doc
  • University of East Anglia, Ph.D.

 

Yang Xie/Vice President  Biology

 

  • Forma Therapeutics
  • Novartis Presidential Postdoc Fellow
  • Yale University, Ph.D.
 
 

Tian Zhu/VP BD

 

  • Former Assistant Director, Early Drug R&D Department, Betta
  • University of Illinois at Chicago, Ph.D.
 

Yanping Wang/Pharmacology VP

 

  • Former Assistant Director, Early Drug R&D Department, Betta
  • University of Illinois at Chicago, Ph.D.
 
 

Yuli Ding/VP of Clinical Operations

 

  • Head of Clinical R&D in Sihuan Pharmacential Ltd, etc.
  • Immunology TA head in J&J and worked as GTM in J&J Netherland and Belgium office
  • Pharmacology M.S. in Inner-Mongolia Medical University.
 

Andrea Wang-Gillam/ CMO and Senior Vice President

 

  • Dr. Wang-Gillam has more than 10 years of experience in clinical research and development in the field of oncology.
  • Dr. Wang-Gillam obtained her doctorate of medicine and of philosophy (MD-PhD) from University of Arkansas for Medical Sciences in May 2001. Dr. Wang-Gillam has been a medical oncology specialist certified by the American Board of Internal Medicine (ABIM) since 2007. 
 
 

Hong Zhuang/Senior Vice President of CMC

 

  • Bachelor and Master degrees in science from Peking University
  • Ph.D. degree in Pharmaceutics and Pharmaceutical Chemistry from the University of Utah
  • Senior Director of Drug Product Development and Manufacturing in Turning Point Therapeutics
  • Senior Research Scientist/Principal Research Scientist in Eli Lilly and Company
 
 
 

Jian Kang/Vice President of IP

 

  • Principal, Spruson & Ferguson
  • Senior patent attorney, Bayer China
  • Peking Union Medical College, Medical Doctor
  • ​Peking University, Bachelor
  • Qualified as PRC patent attorney & attorney-at-law